Three types of macrophagic cells in the mesentery of mice with special reference to LYVE-1-immunoreactive cells

Biomedical Research (Japan)

Volumn 35, Issue 1, 2014, Pages 37-45

  Zheng, Miao ^a   Kimura, Shunsuke ^a   Nio Kobayashi, Junko ^a   Takahashi Iwanaga, Hiromi ^a   Iwanaga, Toshihiko ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; F4 80 ANTIBODY; LIPOPOLYSACCHARIDE; LYVE 1 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONNECTIVE TISSUE; DENDRITIC CELL; DYNAMICS; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LIVER SINUSOID; LUNG ALVEOLUS; MACROPHAGE; MESENTERY; MOUSE; NONHUMAN; PARENCHYMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; VISCERA;

ANIMALS; ANTIGENS, DIFFERENTIATION; FEMALE; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MESENTERY; MICE;

EID: 84896870215     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.35.37     Document Type: Article

References (23)

1. Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, Sugioka K, Naruko T, Asakawa T and Ueda M (2010) Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J Gastroenterol 45, 317-325.
2. Austin JW, Gilchrist C and Fehlings MG (2012) High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation. J Neuochem 122, 344-355.
3. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M and Jackson DG (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144, 789-801.
4. Biewenga J, Van Der Ende MB, Krist LF, Borst A, Ghufron M and Van Rooijen N (1995) Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopula tion of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res 280, 189-196.
5. Böckle BC, Sölder E, Kind S, Romani N and Sepp NT (2008) DC-SIGN+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 29, 187-192.
6. Fraser JRE, Kimpton WG, Laurent TC, Cahill RNP and Vakakis N (1988) Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 256, 153-158.
7. Fraser JR and Laurent TC (1989) Turnover and metabolism of hyaluronan. Ciba Found Sym 143, 41-53.
8. Grant AJ, Goddard S, Ahmed-Choudhury J, Reynolds G, Jackson DG, Briskin M, Wu L, Hübscher SG and Adams DH (2001) Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160, 1445-1455.
9. Holub M, Vetvicka V, Riha I, Svobodova J and Mohelska H (1990) Omental dendritic cells: Ia expression and relation to macrophages. APMIS 98, 1113-1122.
10. Jackson DG (2004) Biology of the lymphatic marker LYVE- 1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 112, 526-538.
11. Johnson LA, Prevo R, Clasper S and Jackson DG (2007) Inflammation- induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 282, 33671-33680.
12. Kato S, Shimoda H, Ji RC and Miura M (2006) Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 81, 71-83.
13. Laurent TC and Fraser JRE (1992) Hyaluronan. FASEB J 6, 2397-2404.
14. Lee H-W, Qin Y-X, Kim Y-M, Park E-Y, Hwang J-S, Huo G-H, Yang C-W, Kim W-Y and Kim J (2011) Expression of lymphatic endothelium-specific hyaluronan receptor LYVE-1 in the developing mouse kidney. Cell Tissue Res 343, 429-444.
15. Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI and Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61, 8079-8084.
16. Muto J, Yamasaki K, Taylor KR and Gallo RL (2009) Engagement of CD44 by hyaluronan suppresses TRL4 signaling and the septic response to LPS. Mol Immunol 47, 449-4565.
17. Oliver G (2004) Lymphatic vasculature development. Nat Rev Immunol 4, 450-457.
18. Prevo R, Banerji S, Fergusson D and Jackson DG (2001) Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276, 19420-19430.
19. + macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 209, 67-77.
20. Wardrop KE and Dominov JA (2011) Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle. J Histochem Cytochem 59, 167-179.
21. Yasuda T (2007) Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-kappaB via ICAM-1. Inflamm Res 56, 246-253.
22. Yasuda T (2010) Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med 220, 229-235.
23. Zhu H, Naito M, Umezu H, Moriyama H, Takatsuka H, Takahashi K and Shultz LD (1997) Macrophage differentiation and expression of macrophage colony-stimulating factor in murine milky spots and omentum after macrophage elimination. J Leukoc Biol 61, 436-444.